Q1 2022 Holdings
Filed 2022-05-16 | 20 holdings | $42.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc.(COGT) | COMMON STOCK | 19240Q201 | $22.3M | 2,981,042 | 52.8% |
| Aclaris Therapeuitics, Inc.(ACRS) | COMMON STOCK | 00461U105 | $19.7M | 1,144,939 | 46.7% |
| Iveric Bio, Inc.(OPHTEUR) | COMMON STOCK | 46583P102 | $42.4K | 2,516,920 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | COMMON STOCK | 92790C104 | $24.3K | 1,314,000 | 0.1% |
| Geron Corporation(GERN) | COMMON STOCK | 374163103 | $19.4K | 14,285,715 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COMMON STOCK | 23257D103 | $18.4K | 5,905,400 | 0.0% |
| Aerovate Therapeutics, Inc. | COMMON STOCK | 008064107 | $16.3K | 889,572 | 0.0% |
| Chinook Therapeutics, Inc.(290A) | COMMON STOCK | 16961L106 | $14.4K | 882,353 | 0.0% |
| Tyra Biosciences, Inc.(TYRA) | COMMON STOCK | 90240B106 | $9.6K | 896,418 | 0.0% |
| Tango Therapeutics, Inc.(TNGX) | COMMON STOCK | 87583X109 | $9.5K | 1,254,500 | 0.0% |
| Alpine Immune Sciences, Inc.(NVLSEUR) | COMMON STOCK | 02083G100 | $9.3K | 1,034,222 | 0.0% |
| Kura Oncology, Inc.(KURA) | COMMON STOCK | 50127T109 | $8.1K | 506,423 | 0.0% |
| Merus N.V. | COMMON STOCK | N5749R100 | $7.9K | 300,000 | 0.0% |
| Akouos, Inc. | COMMON STOCK | 00973J101 | $6.4K | 1,350,006 | 0.0% |
| Magenta Therapeutics, Inc. | COMMON STOCK | 55910K108 | $6.2K | 2,124,122 | 0.0% |
| Entrada Therapeutics, Inc.(TRDA) | COMMON STOCK | 29384C108 | $6.1K | 663,694 | 0.0% |
| Zai Lab LTD(ZLAB) | COMMON STOCK | 98887Q104 | $4.2K | 95,000 | 0.0% |
| Pardes Biosciences, Inc. | COMMON STOCK | 69945Q105 | $1.7K | 229,100 | 0.0% |
| AnaptysBio, Inc.(ANAB) | COMMON STOCK | 032724106 | $1.4K | 58,515 | 0.0% |
| Elevation Oncology, Inc. | COMMON STOCK | 28623U101 | $1.4K | 555,000 | 0.0% |